Moxifloxacin Mixed Augmented Amniotic Membrane Transplantation for Perforating Infectious Keratitis.
10.3341/jkos.2012.53.2.342
- Author:
Hong Kyun KIM
1
Author Information
1. Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea. okeye@knu.ac.kr
- Publication Type:Case Report
- Keywords:
Amniotic membrane;
Corneal perforation;
Corneal ulcer;
Fibrin glue;
Moxifloxacin
- MeSH:
Amnion;
Aza Compounds;
Corneal Perforation;
Corneal Ulcer;
Fibrin Tissue Adhesive;
Humans;
Keratitis;
Quinolines;
Recurrence;
Transplants
- From:Journal of the Korean Ophthalmological Society
2012;53(2):342-347
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report the clinical results of moxifloxacin mixed augmented amniotic membrane transplantation (AMT) in 2 patients with perforating infectious keratitis. CASE SUMMARY: Moxifloxacin mixed augmented amniotic membrane transplantations were performed in 2 patients with rapidly deteriorating deep perforated bacterial keratitis. All patients preserved their eyesight. Complete re-epithelization over the amniotic membrane were observed within a month. The corneal surfaces were healed with opacity, and there were no active infectious infiltrations or recurrences for 3 months after application. CONCLUSIONS: Moxifloxacin mixed augmented AMT has proven to be successful both tectonically and physiologically for cases with perforating active bacterial keratitis.
